Launch of mycoplasma antigen kit Ribotest™ Mycoplasma

August 6, 2013
Asahi Kasei Pharma Corp.

Asahi Kasei Pharma launched the sale of its mycoplasma antigen kit Ribotest™ Mycoplasma on August 8, 2013. Manufacturing and marketing approval for Ribotest™ Mycoplasma was obtained in December 2012, and coverage under Japan’s National Health Insurance began on August 1, 2013.

Developed jointly by Asahi Kasei Corp. and Asahi Kasei Pharma Corp., Ribotest™ Mycoplasma is a rapid diagnostic test kit to aid the diagnosis of mycoplasma infection. Ribotest™ Mycoplasma uses immunochromatography1 to enable simple testing with high specificity. The new product meets the need for a simple and rapid mycoplasma antigen test kit, as previously available methods to test for mycoplasma infection were time-consuming and required difficult manipulation. Ribotest™ Mycoplasma is thus expected to make a significant contribution to rapid diagnosis of mycoplasma infection. It will be sold by Kyokuto Pharmaceutical Industrial Co., Ltd.

Overview of Ribotest™ Mycoplasma

Measurement item:   Mycoplasma antigen (qualitative)
Measurement method:   Immunochromatography
Purpose of measurement:   Detection of mycoplasma pneumoniae2 antigen in liquid wiped from pharynx
(aiding diagnosis of mycoplasma infection)
Measurement time:   15 minutes
Date of approval for manufacturing and marketing:   December 20, 2012
Manufactured and distributed by:   Asahi Kasei Pharma Corp.
Distributed by:   Kyokuto Pharmaceutical Industrial Co., Ltd.

1 An immunoassay method that utilizes an antigen-antibody reaction. It enables simple determination of a positive or negative result by simple visual observation of the presence or absence of a colored line, without the need for any special equipment.

2 The bacterium that causes mycoplasma pneumonia. This disease frequently occurs in children and juveniles, characterized by fever, headache, and persistent dry coughing.


Adobe Readeris required to view these PDF files.

page top